More importantly, differentiated Th cells, including Th1, Th2, Th9, and Th17 cells, generated from the naïve CD4+ T cells of OT-II mice were transferred to B16-OVA tumor-bearing mice. This evidence concerns the gene CD4 and neoplasm.